sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 11, 2026

Is Wells Fargo (WFC) Offering Opportunity After Recent Share Price Pullback?

View original at finance.yahoo.com
Is Wells Fargo (WFC) Offering Opportunity After Recent Share Price Pullback? Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Broader discussions about interest rates, credit quality and regulation continue to frame how investors assess risk and upside for large banks like Wells Fargo, explaining why share price can move without stock-specific developments

    60% confidence
  • Wells Fargo's 1-year return of 3.2% is lagging behind its large US bank peers

    60% confidence
  • The Excess Returns model uses a Stable EPS estimate of $7.91 per share based on weighted future Return on Equity estimates from 18 analysts

    60% confidence
  • Wells Fargo scores a full 6 out of 6 on Simply Wall St's valuation checks

    60% confidence
  • The Stable Book Value of $59.58 per share is sourced from weighted future Book Value estimates from 15 analysts

    60% confidence
  • Wells Fargo's Excess Returns model implies an intrinsic value of approximately $128.16 per share, indicating the stock is materially undervalued by roughly 41.0% relative to the current share price of ~$75.64

    60% confidence

Data points we hold from this source

Wells Fargo & Company · eps7.91 USD_per_share
Wells Fargo & Company · margin13.27 percent
Wells Fargo & Company · stock price75.64 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Is Wells Fargo (WFC) Offering Opportunity After Recent Share Price Pullback? — Source | Via News | pt.VIA.NEWS